Matti Nykter

Получаване на мой собствен потребителски профил

Позовавания

	Всички	От 2020
Позовавания	15877	9132
h-индекс	55	45
i10-индекс	119	105

1900

950

475

1425

20082009201020112012201320142015201620172018201920202021202220232024202547 61 74 118 170 316 450 572 892 1083 1300 1517 1720 1850 1867 1687 1686 313

Публичен достъп

Преглед на всички

135 статии

12 статии

налични

неналични

Въз основа на изисквания при финансирането

Съавтори

Matti AnnalaResearcher, Tampere UniversityПотвърден имейл адрес: tuni.fi
Olli Yli-HarjaTampere University, Faculty of Medicine and Health TechnologyПотвърден имейл адрес: tuni.fi
Ilya ShmulevichProfessor, Institute for Systems BiologyПотвърден имейл адрес: systemsbiology.org
Alexander WyattAssociate Professor, University of British ColumbiaПотвърден имейл адрес: prostatecentre.com
Wei Zhang PhD, Professor of Cancer...The Comprehensive Cancer Center of Wake Forest Baptist Medical CenterПотвърден имейл адрес: wakehealth.edu
Hannu HaapasaloПотвърден имейл адрес: fimlab.fi
Pekka RuusuvuoriUniversity of TurkuПотвърден имейл адрес: utu.fi
Leena LatonenUniversity of Eastern FinlandПотвърден имейл адрес: uef.fi
Sinja TaavitsainenPostdoctoral researcher, Karolinska InstituteПотвърден имейл адрес: ki.se
"G. Steven Bova", "GS Bova", "George..."Tampere University School of Medicine and Health Technology","BioMediTech","Johns HopkinsПотвърден имейл адрес: telamon1.us
Merja HeinäniemiUniversity of Eastern FinlandПотвърден имейл адрес: uef.fi
Olli LohiHead of Division, Pediatric Hematology & OncologyПотвърден имейл адрес: uta.fi
Jake LinFaculty of Medicine and Health Technology, Tampere UniversityПотвърден имейл адрес: helsinki.fi
Kimmo KartasaloAssistant Professor, Karolinska institutetПотвърден имейл адрес: ki.se
Nathan D. PriceProfessor, Buck Institute for Research on AgingПотвърден имейл адрес: buckinstitute.org
Alfonso UrbanucciFaculty of Medicine and Health Technology, prostate cancer research center, Tampere UniversityПотвърден имейл адрес: tuni.fi
Stephen RamseyAssociate Professor, Oregon State UniversityПотвърден имейл адрес: oregonstate.edu
Da YangAssociate Professor, University of PittsburghПотвърден имейл адрес: pitt.edu
Brittany C. Parker Kerrigan, PhDMD Anderson Cancer Center, Dept. of NeurosurgeryПотвърден имейл адрес: mdanderson.org
Kirsi RautajokiFaculty of Medicine and Health Technology, Tampere University, Tampere, FinlandПотвърден имейл адрес: tuni.fi

Следене

Matti Nykter

Tampere University

Потвърден имейл адрес: tuni.fi - Начална страница

Computational biology cancer genomics bioinformatics


Заглавие Сортиране по цитати Сортиране по година Сортиране по заглавие	Позовавания Позовавания	Година
The molecular taxonomy of primary prostate cancer A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ... Cell 163 (4), 1011-1025, 2015	2830	2015
The evolutionary history of lethal metastatic prostate cancer G Gundem, P Van Loo, B Kremeyer, LB Alexandrov, JMC Tubio, ... Nature 520 (7547), 353-357, 2015	1510	2015
Critical assessment of automated flow cytometry data analysis techniques N Aghaeepour, G Finak, FlowCAP Consortium, Dream Consortium, ... Nature methods 10 (3), 228-238, 2013	683	2013
Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis H Cheng, L Zhang, DE Cogdell, H Zheng, AJ Schetter, M Nykter, ... PloS one 6 (3), e17745, 2011	569	2011
Driver fusions and their implications in the development and treatment of human cancers Q Gao, WW Liang, SM Foltz, G Mutharasu, RG Jayasinghe, S Cao, ... Cell reports 23 (1), 227-238. e3, 2018	566	2018
Circulating tumor DNA genomics correlate with resistance to abiraterone and enzalutamide in prostate cancer M Annala, G Vandekerkhove, D Khalaf, S Taavitsainen, K Beja, ... Cancer discovery 8 (4), 444-457, 2018	514	2018
Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer D Yang, Y Sun, L Hu, H Zheng, P Ji, CV Pecot, Y Zhao, S Reynolds, ... Cancer cell 23 (2), 186-199, 2013	453	2013
Evaluation of methods for modeling transcription factor sequence specificity MT Weirauch, A Cote, R Norel, M Annala, Y Zhao, TR Riley, ... Nature biotechnology 31 (2), 126-134, 2013	421	2013
Concordance of circulating tumor DNA and matched metastatic tissue biopsy in prostate cancer AW Wyatt, M Annala, R Aggarwal, K Beja, F Feng, J Youngren, A Foye, ... JNCI: Journal of the National Cancer Institute 109 (12), djx118, 2017	418	2017
Genomic alterations in cell-free DNA and enzalutamide resistance in castration-resistant prostate cancer AW Wyatt, AA Azad, SV Volik, M Annala, K Beja, B McConeghy, ... JAMA oncology 2 (12), 1598-1606, 2016	384	2016
Function of C/EBPδ in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals V Litvak, SA Ramsey, AG Rust, DE Zak, KA Kennedy, AE Lampano, ... Nature immunology 10 (4), 437-443, 2009	334	2009
Gene expression dynamics in the macrophage exhibit criticality M Nykter, ND Price, M Aldana, SA Ramsey, SA Kauffman, LE Hood, ... Proceedings of the National Academy of Sciences 105 (6), 1897-1900, 2008	272	2008
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma BC Parker, MJ Annala, DE Cogdell, KJ Granberg, Y Sun, P Ji, X Li, ... The Journal of clinical investigation 123 (2), 2013	267	2013
A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding Q Huang, T Whitington, P Gao, JF Lindberg, Y Yang, J Sun, MR Väisänen, ... Nature genetics 46 (2), 126-135, 2014	236	2014
Treatment outcomes and tumor loss of heterozygosity in germline DNA repair–deficient prostate cancer M Annala, WJ Struss, EW Warner, K Beja, G Vandekerkhove, A Wong, ... European urology 72 (1), 34-42, 2017	235	2017
Circulating tumor DNA abundance and potential utility in de novo metastatic prostate cancer G Vandekerkhove, WJ Struss, M Annala, HML Kallio, D Khalaf, ... European urology 75 (4), 667-675, 2019	193	2019
Immunogenomic landscape of hematological malignancies O Dufva, P Pölönen, O Brück, MAI Keränen, J Klievink, J Mehtonen, ... Cancer Cell 38 (3), 380-399. e13, 2020	182	2020
Circulating tumor DNA reveals clinically actionable somatic genome of metastatic bladder cancer G Vandekerkhove, T Todenhöfer, M Annala, WJ Struss, A Wong, K Beja, ... Clinical Cancer Research 23 (21), 6487-6497, 2017	170	2017
Loss of PTEN is associated with aggressive behavior in ERG-positive prostate cancer KA Leinonen, OR Saramäki, B Furusato, T Kimura, H Takahashi, S Egawa, ... Cancer epidemiology, biomarkers & prevention 22 (12), 2333-2344, 2013	164	2013
Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression L Latonen, E Afyounian, A Jylhä, J Nättinen, U Aapola, M Annala, ... Nature communications 9 (1), 1176, 2018	159	2018

Системата не може да изпълни операцията сега. Опитайте отново по-късно.

Статии 1–20

Позовавания годишно

Дублирани описания

Обединени библиографски описания

Добавяне на съавториСъавтори

Следене

Позовавания

Съавтори